On-Demand Webinars

  1. Advancing Clinical-Grade TIL Therapy Manufacturing 6/11/2026

    TIL therapy continues to advance, but manufacturing complexity limits its potential. See how automated workflows for generating tumor-reactive T cells can improve consistency, scalability, and readiness.

  2. Automated And Streamlined Manufacturing Of TIL Therapies 6/11/2026

    Advances in TIL therapy are driving a shift from manual processes to streamlined, automated manufacturing. Discover how improved workflows and early clinical results are shaping cancer treatments.

  3. Using Residual DNA Quantification Data To De-Risk mAb Development 6/11/2026

    Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.

  4. The AI Advantage For Regulated Manufacturing 6/10/2026

    Transitioning from paper batch records to human-centered AI optimizes pharma manufacturing. Learn to secure data, cut review times by 90%, and build a strong Return on Automation business case.

  5. Viral Safety Testing In Biologics: Detecting What Current Methods Miss 6/10/2026

    Biologics face unpredictable risks as complexity grows; evolving testing strategies to broaden detection, address gaps, and strengthen safety confidence without disrupting development or compliance.

  6. Cracking Complexity: Learnings From 70+ Bispecific Antibody Programs 6/9/2026

    The goal is practical: help development teams make early decisions that balance speed, quality, and risk and support a smoother path to the clinic.

  7. Streamlining Discovery And Development Workflows Using Engineered P. fluorescens Strains For ncAA Incorporation And Extracellular Protein Production 6/8/2026

    Pseudomonas fluorescens offers a purpose-built alternative to conventional expression systems. Strain engineering platforms built around this organism can improve yields and simplify process development.

  8. Accelerating Antibody Development: A Proven Path From Gene To GMP 6/5/2026

    Discover how an optimized, end-to-end development strategy can help sponsors reach key clinical milestones faster and bring potentially life-saving therapies to patients sooner.

  9. From Gene Editing To NGS-Based T Cell Characterization 6/4/2026

    Gene-edited T cells targeting PD-1 and TIGIT are redefining approaches to cancer therapy. Explore how cell engineering and integrated genomic workflows uncover critical insights into T cell function.

  10. Efficient mAb Development With A Flexible Purification Toolkit 6/4/2026

    Increasing mAb complexity is pushing purification beyond traditional platforms. See how flexible chromatography, optimized buffers, and adaptable workflows are becoming essential to achieve target purity.